Injective (INJ) is currently trading at $4.60, having experienced a slight decline of 0.99805% over the last 24 hours. The daily range has been narrow, with a high of $4.68 and a low of $4.50, indicating subdued trading activity and potential consolidation within this price band.

Volume stands at approximately $35.9 million, with a volume-to-market cap ratio of 7.82%, suggesting moderate liquidity. The short-term moving averages reflect mixed signals; while the 8 and 13 SMA show slight upward momentum, the longer 55 and 144 SMA indicate bearish pressure, highlighting a potential trend reversal.

The 1-hour RSI is at 53, suggesting neutral momentum, while the 7-day RSI at 43 indicates bearish sentiment over the medium term. Over the past week, INJ has dropped by about 13.97%, and the 14-day change also shows a decline of 10.73%, signifying a broader downward trend.

Given the historical context, the all-time high of $52.62 reached in March 2024 remains a distant target, underscoring significant market retracement. Current price levels are substantially below previous highs, and the recent price action suggests ongoing weakness.

Considering the technical indicators and price trends, a Hold rating is recommended for INJ. The asset shows potential for short-term rebounds given its current consolidation phase, but the overall bearish sentiment and declining RSI suggest that further downside could be likely before a more substantial recovery can take place.